TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bionordika AS
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 3,995 | 5,140 | 6,817 |
Financial expenses | 69 | 66 | 72 |
Earnings before taxes | 317 | 1,050 | 1,956 |
Total assets | 1,623 | 2,533 | 3,650 |
Current assets | 1,562 | 2,489 | 3,613 |
Current liabilities | 957 | 1,792 | 2,898 |
Equity capital | 655 | 722 | 752 |
- share capital | 9 | 10 | 10 |
Employees (average) | 10 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 40.4% | 28.5% | 20.6% |
Turnover per employee | 682 | ||
Profit as a percentage of turnover | 7.9% | 20.4% | 28.7% |
Return on assets (ROA) | 23.8% | 44.1% | 55.6% |
Current ratio | 163.2% | 138.9% | 124.7% |
Return on equity (ROE) | 48.4% | 145.4% | 260.1% |
Change turnover | -819 | -1,318 | -615 |
Change turnover % | -17% | -20% | -8% |
Chg. No. of employees | -3 | ||
Chg. No. of employees % | -23% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.